BKZ Stock Overview
Suntar Eco-City Limited, an investment holding company, engages in the health and nutrition, and property development businesses in the People’s Republic of China.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Suntar Eco-City Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | S$0.10 |
52 Week High | S$0.16 |
52 Week Low | S$0.075 |
Beta | 1.02 |
1 Month Change | 37.33% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | -85.18% |
5 Year Change | -31.33% |
Change since IPO | -96.62% |
Recent News & Updates
Shareholder Returns
BKZ | SG Healthcare | SG Market | |
---|---|---|---|
7D | 0% | 0.7% | 3.1% |
1Y | n/a | -24.2% | -4.8% |
Return vs Industry: Insufficient data to determine how BKZ performed against the SG Healthcare industry.
Return vs Market: Insufficient data to determine how BKZ performed against the SG Market.
Price Volatility
BKZ volatility | |
---|---|
BKZ Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 6.6% |
Market Average Movement | 5.0% |
10% most volatile stocks in SG Market | 16.0% |
10% least volatile stocks in SG Market | 2.2% |
Stable Share Price: BKZ's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine BKZ's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2006 | n/a | Chunguang Lan | www.suntar.com.sg |
Suntar Eco-City Limited, an investment holding company, engages in the health and nutrition, and property development businesses in the People’s Republic of China. The company operates through two segments, Health and Nutrition Products and Property Development. It offers health and nutrition products, eco-tourism, and real estate development and management services.
Suntar Eco-City Limited Fundamentals Summary
BKZ fundamental statistics | |
---|---|
Market cap | S$6.46m |
Earnings (TTM) | S$120.65k |
Revenue (TTM) | S$6.65m |
53.6x
P/E Ratio1.0x
P/S RatioIs BKZ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BKZ income statement (TTM) | |
---|---|
Revenue | CN¥35.42m |
Cost of Revenue | CN¥34.28m |
Gross Profit | CN¥1.14m |
Other Expenses | CN¥498.00k |
Earnings | CN¥643.00k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.01 |
Gross Margin | 3.22% |
Net Profit Margin | 1.82% |
Debt/Equity Ratio | 0% |
How did BKZ perform over the long term?
See historical performance and comparison